India’s First Indigenous IBR Vaccine

On 29th September 2025, Indian Immunologicals Limited launched India’s first indigenously developed glycoprotein E (gE) deleted DIVA marker vaccine against infectious bovine rhinotracheitis (IBR), named Raksha-IBR.

  • The vaccine enables differentiation between infected and vaccinated animals.
  • The vaccine targets infectious bovine rhinotracheitis (IBR), caused by Bovine Herpes Virus 1 (BHV-1).
  • IBR spreads through aerosols and infected bull semen, primarily affecting the reproductive system of cattle.
  • Major impacts of IBR include infertility, abortions, and reduced milk productivity.
  • No prior vaccine or specific treatment for IBR existed in India before Raksha-IBR.
  • Use of the vaccine protects genetically superior bulls, safeguarding breeding programs and milk production ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Buy December 2025 Issue

Already a Member? Login here

Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Be an Annual Subscriber

Related Content